Use of Biologic Therapy by Pregnant Women with Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines

BACKGROUND & AIMS: In women with inflammatory bowel diseases (IBD), exposure to immunomodulator or biologic therapy has not been associated with adverse events during pregnancy or outcomes of newborns. We investigated whether exposure of patients to these agents during pregnancy affects serologi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Gastroenterol Hepatol
Main Authors: Beaulieu, Dawn B., Ananthakrishnan, Ashwin N., Martin, Christopher, Cohen, Russell D., Kane, Sunanda V., Mahadevan, Uma
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735029/
https://ncbi.nlm.nih.gov/pubmed/28870657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2017.08.041
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares